Activity ID
4644Expires
March 8, 2026Format Type
InternetCME Credit
1Fee
$150CME Provider: Louisiana Medical Mutual Insurance Company (LAMMICO)
Description of CME Course
Not so long ago, bariatric or obesity surgery was considered experimental and not covered by health insurance. Now, numerous high-quality randomized controlled studies have shown that metabolic surgery has powerful antidiabetic effects for obese Type 2 Diabetic (T2D) patients. In most cases it can cause remission of diabetes and prevent the development of complications of diabetes. Even those not achieving remission have improved glycemic control, reduced medication regimens, and reduced complications of diabetes. This activity will review the current guidelines and offer recommendations on educating patients on the new evidence.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Anesthesiology
Family Medicine
Physical Medicine and Rehabilitation
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
• Explain the evolution of patient selection criteria in metabolic surgery for obese T2D patients.
• Describe the research findings underlying the current recommendations to treat diabetes type 2 with metabolic surgery.
• Educate obese T2D patients on the risks and benefits of metabolic surgery.
Keywords
Diabetes, Type 2 Diabetes, bariatric surgery, metabolic surger
Competencies
Interpersonal & Communication Skills, Medical Knowledge, Patient Care & Procedural Skills, Practice-based Learning & Improvement, Systems-based Practice
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military
